Qinghai Spring Medicinal Resources Technology Co., Ltd.

¥4.02As of Sun 8 Nov 2026, 12:00 UTC
SSE:600381Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (10.38%)
Div yield —
ROE (9.49%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.74
PE TTM —
TSR TTM (17.62%)
Mkt cap ¥2.301B
ROIC (12.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.11
2.20%
(68.30%)
Hold 2|8|8|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.05
2.65%
(0.32%)
(2.68%)
9.04%
Revenue¥M
167.4
164.2
164.3
164.4
11.54%
3.27%
0.49%
1.98%
Peers (US$344.9M)
Cap (US$)
PE
349.0M
31.54x
332.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.751
1.546
1.181
EBIT/Intx
0.567
0.326
0.306
Own earn%
28.78
64.12
57.34
Sh yield%
46.23
31.24
33.99
Owners
Insiders/Inst%
11.55
60.61
Short interest%
1.54
SBC / revenue%
1.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
6–11
$1 testx
−0.6
Incr. ROIC%
2